Immunovant Inc’s filing revealed that its Chief Technology Officer Stout Jay S unloaded Company’s shares for reported $51461.0 on Jan 21 ’26. In the deal valued at $26.03 per share,1,977 shares were sold. As a result of this transaction, Stout Jay S now holds 197,634 shares worth roughly $5.14 million.
Then, Stout Jay S sold 1,203 shares, generating $31,914 in total proceeds. Upon selling the shares at $26.53, the Chief Technology Officer now owns 199,611 shares.
Before that, Van Tuyl Christopher sold 10,813 shares. Immunovant Inc shares valued at $290,943 were divested by the Chief Legal Officer at a price of $26.91 per share. As a result of the transaction, Van Tuyl Christopher now holds 149,930 shares, worth roughly $3.9 million.
Wolfe Research upgraded its Immunovant Inc [IMVT] rating to an Outperform from a a Peer perform in a research note published recently. A number of analysts have revised their coverage, including Truist’s analysts, who began to cover the stock in mid October with a ‘”a Hold”‘ rating. Jefferies started covering the stock on March 03, 2025. It rated IMVT as “a Hold”.
Price Performance Review of IMVT
On Friday, Immunovant Inc [NASDAQ:IMVT] saw its stock fall -0.65% to $26.01. Over the last five days, the stock has gained 0.04%. Immunovant Inc shares have risen nearly 11.97% since the year began. Nevertheless, the stocks have risen 2.32% over the past one year.
How much short interest is there in Immunovant Inc?
A steep rise in short interest was recorded in Immunovant Inc stocks on 2025-12-31, growing by 1.07 million shares to a total of 16.14 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-28 was 15.07 million shares. There was a rise of 6.61%, which implies that there is a positive sentiment for the stock.
